Spotlight to Remain on Aerochamber as Top Choice for Asthma Spacers

2021-09-21

仿制药并购合作专利到期

Higher Healthcare Spending Positions North America to Create US$ 729.9 Mn worth Opportunity in Global Asthma Spacers Market The asthma spacers market study by Fact.MR offers compelling insights into key growth drivers and restraints impacting the market through 2031. The survey offers asthma spacers demand outlook and studies opportunities existing in key segments, including product and disease type. It also highlights key strategies adopted by market players to increase asthma spacers sales. Fact.MR– A Market Research and Competitive Intelligence Provider: The global market for asthma spacers is forecast to grow at a CAGR of 3.9% over the assessment period 2021-2031, surpassing valuation of US$ 1803.9 Mn by the end of 2031. Growing prevalence of respiratory diseases including asthma and chronic obstructive pulmonary disease (COPD) are driving demand for asthma spacers. According to a study by World Health Organization (WHO), asthma affected around 262 million people and caused around 461000 deaths in 2019. Apart from this, rising incidence of asthma especially among elderly population is pushing demand for asthma spacers. As per the World Health Organization (WHO), by 2050, the number of people aged 60 years and above will two billion, accounting for 22% of the total global population. It is also demonstrated in studies that 7 out of 10 patients are unable to use inhaler devices effectively. Therefore, to improve the intake of medication, the demand for asthma spacers is skyrocketing. Among various product types, aerochambers are gaining traction owing to their enhanced capability of medicine delivery in a slow and controlled manner. As per Fact.MR, the segment is anticipated to grow at a healthy CAGR over the forecast period. Meanwhile, he demand for devices such as micro spacers and flexi-chambers are expected to grow at 3.9% CAGR between 2021 and 2031. The North America market for asthma spacers is forecast to register steady rate of growth over the forthcoming years on account of rising incidence of asthma coupled with increasing healthcare spending. Meanwhile, rapid developments taking place in the healthcare sector are driving demand for Asia-Pacific market. “Increasing cases of respiratory diseases along with rising level of pollution are supporting growth of the asthma spacers market. Apart from this, leading manufacturers are adopting various organic and inorganic strategies such as collaboration and product launches to strengthen their footprint,” says a Fact.MR analyst. For More Information On How To Improve Your Asthma Spacers Market Footprint, Request A Sample Here Key Takeaways from Asthma Spacers Market Survey North America has emerged as the leading market for asthma spacers and is estimated to reach a valuation of US$ 729.9 Mn by the end of 2031. Backed by increasing healthcare spending, Asia-Pacific market is poised to expand at a CAGR of 4.5% over the forthcoming years. Based on product type, the demand for micro spacers and flexi-chambers are anticipated to grow at 3.9% over the forecast period 2021-2031. The global asthma spacers market is projected to grow at a CAGR of 3.9% over the assessment period 2021-2031. The demand for aerochambers is surging rapidly and is estimated to surpass a valuation of US$ 792.94 Mn by the end of 2031. Key Drivers Increasing prevalence of respiratory diseases such asthma is fuelling the market growth. Increasing spending on advanced healthcare to access improved patient care is contributing to the market growth. Growing level of air pollution is expected to result in higher incidence of respiratory disorders. This in turn is projected to drive the asthma spacers market Ask Your Asthma Spacers Market Related Questions & Get Customized Reports Competitive Landscape Asthma spacers manufacturers are focusing on launching new product to enhance their product portfolio. Their key focus area also includes acquisitions and partnerships to increase their global footprint. For instance, in 2021, Lupin Healthcare (U.K.), owned subsidiary of Lupin announced the launch of new Luforbec 100/6 μg pMDI, first bradedgeneric asthma inhaler drug for treatment of asthma and COPD in the U.K. In 2021, Philip Morris International announced that it has acquired 22.61% stake in British Asthma Inhaler Firm Asthma Inhaler Firm called Vectura. This acquisition of Vectura will help in transforming PMI by investing in scientific excellence and leveraging its expertise and knowledge. Some of the leading players operating in the asthma spacers market profiled by Fact.MR are: Trudell Medical International Koninklijke Philips N.V GlaxoSmithKline Medical Developments International Visiomed Group Ltd. Cipla Ltd. Clement Clarke AstraZeneca Merck & Co. Lupin Pharmaceuticals Inc. More Valuable Insights on Asthma Spacers Market Fact.MR, in its new report, offers an unbiased analysis of the global asthma spacers market, analyzing forecast statistics through 2021 and beyond. the survey reveals growth projections on asthma spacers market with detailed segmentation: Product Type Aerochambers Optichambers Volumatic Inspirease Others Distribution Channel Retail Pharmacy e-Commerce Hospital Pharmacy Key Regions North America Europe Asia Pacific Latin America Middle East & Africa Key Questions Covered in the Asthma Spacers Market Report The market survey also highlights projected sales growth for asthma spacers market between 2021 and 2031 The report offers insight into asthma spacers demand outlook for forecast period 2021-2031 Asthma spacers market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, collaborations or partnerships, and others Asthma spacers market analysis identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry Explore Fact.MR’s Coverage on the Healthcare Domain Asthma Treatment Market - Asthma therapeutics demand is expected to grow in the coming years, owing to increased patient awareness of the condition. This should have resulted in linear growth of the asthma treatment market; however, a surge in generic drug sales, fuelled by branded drug patent expiration, is expected to limit market potential. During the forecast period, the Asia Pacific region's asthma treatment market is expected to grow at a rapid pace. Virus induced Asthma Treatment Market - The increase in product approvals by the FDA and other regulatory bodies is expected to drive the virus-induced asthma treatment market. Furthermore, the rising prevalence of asthma, as well as strategic approaches such as collaborations and partnerships by market participants, are propelling market growth. Furthermore, the increased opportunities for market players to expand their geographical presence in emerging countries will drive the growth of the global virus-induced asthma treatment market. High Concentration Respiratory Masks Market - The rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease is driving the global market for high concentration respiratory masks. Other major factors expected to drive the growth of the market for high concentration respiratory masks over the forecast period include technological advancements in high concentration respiratory masks such as less use of breathing assistance, usability variance, and adjustable mask fit to the face. About Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Reach out to us with your goals, and we’ll be an able research partner. Contact: Mahendra Singh US Sales Office: 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Tel: +1 (628) 251-1583 E: sales@factmr.com Source: Fact.MR

机构